Pur 4-in-1 Correcting Primer

Description

Acneprimer is a pharmaceutical product indicated for the treatment of acne. The effective date of this formulation is June 6, 2022. An image reference for the product is available as "AcnePrimer.jpg."

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with this condition to help manage and reduce the severity of acne symptoms.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of the product.

For new users, it is recommended to apply the product to a small area once daily for three consecutive days to assess for any sensitivity. If no discomfort is experienced during this testing period, the entire affected area may be covered with a thin layer of the product.

Initial dosing should consist of one application daily. Depending on the patient's response, the frequency may be gradually increased to two or three times daily as needed. In cases where dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day to mitigate these effects.

Contraindications

Use of this product is contraindicated in individuals who may come into contact with the eyes. In the event of contact, it is imperative to rinse thoroughly with water to mitigate potential irritation or harm. No other contraindications have been specified in the provided data.

Warnings and Precautions

For external use only. It is imperative to keep this product out of reach of children. In the event of accidental ingestion, immediate action is required; contact a Poison Control Center or seek medical assistance without delay.

The concurrent use of this product with other topical acne treatments may increase the likelihood of skin irritation and dryness. Should irritation occur, it is recommended to rinse the affected area thoroughly with water. Healthcare professionals should advise patients to monitor for signs of irritation and to discontinue use if severe irritation, burning, or itching develops, at which point consultation with a healthcare professional is advised.

Contact with the eyes must be avoided. In the event of accidental contact, it is essential to rinse the eyes thoroughly with water to mitigate potential harm.

For patients with more severe cases of acne, or if no improvement is observed within 6 to 8 weeks of use, it is advisable to consult a healthcare professional for further evaluation and management.

In rare instances, patients may experience severe allergic reactions, including hives, swelling of the eyes and mouth, blistering, or difficulty breathing. In such cases, immediate medical attention is necessary.

Side Effects

Patients using this product should be aware that it is for external use only and must be kept out of reach of children. In the event of accidental ingestion, it is imperative to contact a Poison Control Center or seek medical assistance immediately.

Common adverse reactions associated with the use of this product include skin irritation and dryness, particularly when used concurrently with other topical acne treatments. Should irritation occur, it is recommended to rinse the affected area thoroughly with water. Patients are also advised to avoid contact with the eyes; if contact does occur, the eyes should be rinsed thoroughly with water.

In more severe cases, patients may experience significant irritation, burning, or itching of the skin. If such symptoms develop, it is crucial to discontinue use and consult a healthcare professional. Additionally, patients should seek immediate medical attention if they experience hives, swelling of the eyes and mouth, blistering, or difficulty breathing.

For patients with more severe conditions or those who do not observe improvement within 6 to 8 weeks of use, consultation with a healthcare professional is recommended.

Drug Interactions

The concurrent use of another topical acne product may increase the likelihood of skin irritation and dryness. In cases where irritation occurs, it is advised to rinse the affected area thoroughly with water to alleviate symptoms. Monitoring for signs of irritation is recommended when combining topical acne treatments.

Packaging & NDC

Below are the non-prescription pack sizes of Pur 4-in-1 Correcting Primer (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to contact a Poison Control Center or seek medical assistance immediately.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy, including safety concerns, dosage modifications, or special precautions. Therefore, healthcare professionals are advised to exercise caution when prescribing this product to pregnant patients. The potential risks and benefits should be carefully considered, and alternative therapies may be explored in consultation with the patient. Women of childbearing potential should be informed of the lack of data and encouraged to discuss any concerns with their healthcare provider.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific concerns have been identified in the available information.

Renal Impairment

There is no information available regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider individual patient factors when prescribing this medication to patients with renal impairment, as specific guidelines are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate action is crucial. If the substance is ingested, it is imperative to contact a Poison Control Center or seek medical assistance without delay.

Healthcare professionals should be aware of the potential symptoms associated with overdosage, which may vary depending on the specific substance involved. Prompt recognition of these symptoms is essential for effective management.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and assessment of the patient's condition are recommended to ensure appropriate interventions are implemented.

In all cases of suspected overdosage, timely communication with poison control and adherence to established medical protocols are vital for optimal patient outcomes.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should call a Poison Control Center or seek medical help immediately.

Patients should be informed that skin irritation and dryness may be more likely to occur if they are using another topical acne product concurrently. In the event of irritation, patients should rinse the affected area thoroughly with water.

It is also important to counsel patients to avoid contact with their eyes. If contact occurs, they should rinse their eyes thoroughly with water to minimize any potential irritation.

Storage and Handling

The product is supplied in packaging that includes specific NDC numbers. It should be stored at a temperature range of 20°C to 25°C (68°F to 77°F) to maintain its efficacy. It is essential to protect the product from light exposure to ensure its stability. Additionally, the carton should be retained for further directions and warning information, which may be necessary for proper handling and usage.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients to keep the product out of reach of children and to seek immediate medical assistance if swallowed. Patients are cautioned that using this product concurrently with other topical acne treatments may increase the likelihood of skin irritation and dryness; in such cases, thorough rinsing with water is recommended.

Patients should avoid contact with the eyes, and if contact occurs, they should rinse thoroughly with water. For cases that do not show improvement within 6-8 weeks, or in the event of severe irritation, burning, or itching, patients are encouraged to consult a healthcare professional. Immediate medical attention is necessary if patients experience hives, swelling of the eyes and mouth, blistering, or difficulty breathing.

Drug Information (PDF)

This file contains official product information for Pur 4-in-1 Correcting Primer, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)